×
About 7,240 results

ALLMedicine™ Angina Pectoris Center

Research & Reviews  1,641 results

HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation
https://clinicaltrials.gov/ct2/show/NCT05489016

Aug 5th, 2022 - Percutaneous coronary intervention (PCI) is currently the main treatment for coronary heart disease. Drug-coated balloon (DCB) is an emerging interventional therapy technology. DCB can effectively reduce the incidence of vascular restenosis and ca...

Treatment of Angina Pectoris After Coronary Revascularization With Integrated Traditional Chinese and Western Medicine
https://clinicaltrials.gov/ct2/show/NCT05482009

Aug 1st, 2022 - The purpose of this study was to observe whether the combination of traditional Chinese medicine intervention on the basis of standardized western medicine treatment could further reduce the incidence of cardiovascular events in patients with angi...

Alcohol consumption and subclinical and clinical coronary heart disease: A Mendelian ra...
https://doi.org/10.1093/eurjpc/zwac156
European Journal of Preventive Cardiology; Hisamatsu T, Miura K et. al.

Jul 31st, 2022 - The potential effect of alcohol consumption on coronary heart disease (CHD) remains unclear. We used the variant rs671 in the aldehyde dehydrogenase 2 gene (ALDH2) as an instrument to investigate the causal role of alcohol intake in subclinical an...

Effect of Low High-Density Lipoprotein Level on Endothelial Activation and Prothromboti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316205
International Journal of Environmental Research and Publi... Lampka M, Olszewska-Słonina D et. al.

Jul 28th, 2022 - High-density lipoproteins (HDL) play an important role in the prevention of atherosclerosis. The aim of the study was to assess the relationship between serum HDL-C concentration and proinflammatory/prothrombic activation in coronary artery diseas...

The Effects of Cardiac Rehabilitation on Sleep Quality and Sleep Duration in Patients After Coronary Artery Bypass Graft
https://clinicaltrials.gov/ct2/show/NCT05474339

Jul 28th, 2022 - Coronary artery disease (CAD) is one of the common cardiovascular diseases, including myocardial infarction and unstable angina pectoris. Using the Global Burden of Disease statistical data analysis in 2020, Khan and other scholars found that the ...

see more →

Guidelines  3 results

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood...
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.

Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...

Recommendations for advancing the care of Canadians living with refractory angina pecto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.

Jul 9th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,

Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications
https://onlinelibrary.wiley.com/doi/abs/10.1111/fcp.12633
Fundamental & Clinical Pharmacology; Ala M, .

Sildenafil, approved two decades ago, is the inhibitor of phosphodiesterase 5 (PDE5). First of all, it was designated for angina pectoris, but soon it showed a wonderful efficacy in erectile dysfunction (ED) and then pulmonary arterial hypertensio...

see more →

Drugs  844 results see all →

Clinicaltrials.gov  288 results

HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation
https://clinicaltrials.gov/ct2/show/NCT05489016

Aug 5th, 2022 - Percutaneous coronary intervention (PCI) is currently the main treatment for coronary heart disease. Drug-coated balloon (DCB) is an emerging interventional therapy technology. DCB can effectively reduce the incidence of vascular restenosis and ca...

Treatment of Angina Pectoris After Coronary Revascularization With Integrated Traditional Chinese and Western Medicine
https://clinicaltrials.gov/ct2/show/NCT05482009

Aug 1st, 2022 - The purpose of this study was to observe whether the combination of traditional Chinese medicine intervention on the basis of standardized western medicine treatment could further reduce the incidence of cardiovascular events in patients with angi...

The Effects of Cardiac Rehabilitation on Sleep Quality and Sleep Duration in Patients After Coronary Artery Bypass Graft
https://clinicaltrials.gov/ct2/show/NCT05474339

Jul 28th, 2022 - Coronary artery disease (CAD) is one of the common cardiovascular diseases, including myocardial infarction and unstable angina pectoris. Using the Global Burden of Disease statistical data analysis in 2020, Khan and other scholars found that the ...

CoROnary SinuS Reducer implantatiOn for ischemiA reDuction
https://clinicaltrials.gov/ct2/show/NCT04121845

Jul 25th, 2022 - Patients with refractory angina pectoris have low quality of life and reduced exertional capacity. Studies have shown that the coronary sinus reducer (CSR) implantation improves the quality of life. However, to date there are no firm objective dat...

Efficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris
https://clinicaltrials.gov/ct2/show/NCT04915157

Jul 21st, 2022 - There are a growing number of patients with refractory angina pectoris (RAP). RAP is defined as a 'chronic condition (> three months) characterized by diffuse coronary artery disease in the presence of proven ischemia, which is not amendable to a ...

see more →

News  115 results

Real-world data suggest coprescribing PDE5 inhibitors and nitrates may be safe
https://www.mdedge.com/internalmedicine/article/253888/mens-health/real-world-data-suggest-coprescribing-pde5-inhibitors
Will Pass

Apr 19th, 2022 - As coprescribing drugs for erectile dysfunction and oral organic nitrates for ischemic heart disease (IHD) surged, cardiovascular adverse events did not significantly increase, a new study finds. The authors of the new research specifically examin.

Hypertension With Right Subclavian Plaque Tied to CV Events
https://www.medscape.com/viewarticle/965796

Dec 30th, 2021 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaways The study demonstrates that the prevalence of right subclavian plaques is an independent risk factor for future c...

MHRA Updates Safety Information On Tofacitinib
https://www.medscape.com/viewarticle/960411

Oct 7th, 2021 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for tofacitinib (Xeljanz) stating that individuals aged >65 years, current or past smokers or individuals with other cardiovascular or malignancy risk f...

Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy
https://www.mdedge.com/fedprac/avaho/article/239977/genitourinary-cancer
Christopher James Little, MD, Bao Sean Nguyen, MD et. al.

May 12th, 2021 - Coronary artery vasospasm is a rare but well-known adverse effect of 5-fluorouracil (5-FU) that can be life threatening if unrecognized. Patients typically present with anginal chest pain and ST elevations on electrocardiogram (ECG) without athero.

AB-205 Shows Tolerability, Robust Effects in Patients With Lymphoma Undergoing HDT-ASCT
https://www.onclive.com/view/ab-205-shows-tolerability-robust-effects-in-patients-with-lymphoma-undergoing-hdt-asct

Mar 23rd, 2021 - The engineered cord endothelial cell (E-CEL) product AB-205 showed an encouraging safety profile along with robust effects in eliminating oral/gastrointestinal (GI) severe regimen-related toxicities (SRRT) in patients with systemic lymphoma underg...

see more →

Patient Education  5 results see all →